stockrowImmunovant, Inc. (IMVT) vs Mirum Pharmaceuticals, Inc. (MIRM)
- Immunovant, Inc. IMVT 30.53 +7.54%
- Mirum Pharmaceuticals, Inc. MIRM 93.82 +0.30%
Immunovant, Inc. and Mirum Pharmaceuticals, Inc. are both Biotechnology companies. Immunovant, Inc. and Mirum Pharmaceuticals, Inc. are of similar size ($6.1B and $5.9B). Immunovant, Inc. has the higher net margin (0.00% vs −134.8%) and the higher return on invested capital (0.00% vs −184.7%). Across the 13 metrics below, Immunovant, Inc. leads on 8 and Mirum Pharmaceuticals, Inc. on 5.
Valuation
Profitability
| Metric | IMVT | MIRM | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 81.72% | 65.16% |
| Operating margin | 0.00% | (133.62%) | 0.00% |
| Net margin | 0.00% | (134.75%) | 0.00% |
| Free cash flow margin | 0.00% | (46.04%) | 0.00% |
| Return on equity | (80.10%) | (760.01%) | (50.12%) |
| Return on assets | (71.10%) | (99.78%) | (45.60%) |
| Return on invested capital | 0.00% | (184.65%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack